Biologics and chronic obstructive pulmonary diseases
The presence of airway inflammation in patients with chronic obstructive pulmonary disease (COPD) provides a rationale for biological agents targeting specific inflammatory pathways. This approach has been strikingly effective in patients with other chronic inflammatory diseases, such as rheumatoid...
| Главный автор: | |
|---|---|
| Формат: | Journal article |
| Язык: | English |
| Опубликовано: |
Elsevier
2018
|